Liver is the most common site of colorectal cancer (CRC) metastases. Treatment of CRC
liver metastases (CRLM) includes different strategies, prevalently based on the clinical and …

Background Patients with polymetastatic cancer are most often treated with systemic therapy
to improve overall survival and/or delay progression, with palliative radiotherapy reserved …

Background Oligometastatic colorectal cancer (CRC) is potentially curable and demands
individualised strategies. Methods This single-centre retrospective study investigated if …

Simple Summary Around half of patients with non-small cell lung cancer (NSCLC) have
metastatic disease at the time of diagnosis. Some patients will have a limited number of …

According to the authors and editors, this report contains the most justified principles of
diagnostic and therapeutic procedures prepared considering the scientific value of evidence …

Radiotherapy as metastasis-directed therapy for oligometasta... : Current Opinion in Urology
Radiotherapy as metastasis-directed therapy for oligometastatic prostate cancer : Current …

Background Metastasis‐directed therapy (MDT) utilizing stereotactic body radiotherapy
(SBRT) for oligoprogressive lesions could provide a delay in next‐line systemic treatment …

Stage IV non-small cell lung cancer (NSCLC) exists on a spectrum, with a subset of patients
presenting with oligometastatic disease involving only a limited number of distant sites. For …

Background: A limited degree of progression after a response to treatment is labelled as
oligoprogression and is a hot topic of metastatic melanoma (MM) management. Rogue …

It has been 25 years since the oligometastatic hypothesis was formally defined and nearly a
century since the first published report of an oligometastatic patient being treated with …